This program led to the discovery of many novel compounds
showing a range of cytotoxic activities,including taxanes,
camptothecins.
Development of taxanes into clinically active agents
spanned a period of some 30 years (1962 to 1992 ).
Preclinical studiesClinical studies Clinical use